Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.89B | $5.31B | $5.83B | $6.26B | $6.67B | $7.78B | $8.08B | $8.54B | $9.26B | $9.47B |
| Revenue growth | — | 8.6% | 9.8% | 7.5% | 6.6% | 16.5% | 3.9% | 5.7% | 8.3% | 2.3% |
| Net income | $821M | $864M | $1.43B | $1.50B | $1.64B | $2.04B | $2.11B | $2.34B | $2.49B | $2.67B |
| Net margin | 16.8% | 16.3% | 24.5% | 24.0% | 24.5% | 26.2% | 26.2% | 27.4% | 26.9% | 28.2% |
| EPS (diluted) | $1.65 | $1.75 | $2.93 | $3.11 | $3.42 | $4.27 | $4.49 | $5.07 | $5.47 | $6.02 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $713M | $1.35B | $1.79B | $1.79B | $2.13B | $2.21B | $1.91B | $2.35B | $2.95B | $2.90B |
| Capital expenditures | $216M | $224M | $338M | $460M | $453M | $477M | $586M | $732M | $655M | $621M |
| Free cash flow | $497M | $1.12B | $1.45B | $1.33B | $1.67B | $1.74B | $1.33B | $1.62B | $2.30B | $2.28B |
| Share buybacks | $300M | $500M | $698M | $626M | $250M | $743M | $1.59B | $1.09B | $1.86B | $248M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $727M | $1.56B | $1.60B | $1.93B | $3.60B | $3.48B | $3.58B | $2.04B | $1.99B | $2.31B |
| Total assets | $7.65B | $8.59B | $10.8B | $11.5B | $13.6B | $13.9B | $14.9B | $14.3B | $14.2B | $15.5B |
| Total liabilities | $6.15B | $6.80B | $8.59B | $8.84B | $9.84B | $9.36B | $10.5B | $9.29B | $9.47B | $12.1B |
| Long-term debt | $4.47B | $4.95B | $6.44B | $5.95B | $6.59B | $6.59B | $6.55B | $6.56B | $5.22B | $9.04B |
| Shareholders' equity | $1.49B | $1.77B | $2.19B | $2.71B | $3.77B | $4.54B | $4.41B | $5.00B | $4.77B | $3.33B |
| Retained earnings | $1.48B | $2.11B | $3.27B | $4.43B | $5.66B | $7.19B | $8.67B | $10.3B | $12.0B | $13.7B |
| Shares (wtd avg diluted) | 498M | 493M | 487M | 482M | 479M | 477M | 470M | 462M | 455M | 444M |
Every figure is extracted from Zoetis Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.